p53 signaling in cancer progression and therapy
The p53 protein is a transcription factor known as the" guardian of the genome" because of
its critical function in preserving genomic integrity. The TP53 gene is mutated in …
its critical function in preserving genomic integrity. The TP53 gene is mutated in …
Mutant p53 in cancer progression and targeted therapies
G Zhu, C Pan, JX Bei, B Li, C Liang, Y Xu, X Fu - Frontiers in oncology, 2020 - frontiersin.org
TP53 is the most frequently mutated tumor suppressor gene in human cancer. The majority
of mutations of p53 are missense mutations, leading to the expression of the full length p53 …
of mutations of p53 are missense mutations, leading to the expression of the full length p53 …
Mutant p53 in cancer: new functions and therapeutic opportunities
PAJ Muller, KH Vousden - Cancer cell, 2014 - cell.com
Many different types of cancer show a high incidence of TP53 mutations, leading to the
expression of mutant p53 proteins. There is growing evidence that these mutant p53s have …
expression of mutant p53 proteins. There is growing evidence that these mutant p53s have …
p53 mutations in cancer
PAJ Muller, KH Vousden - Nature cell biology, 2013 - nature.com
In the past fifteen years, it has become apparent that tumour-associated p53 mutations can
provoke activities that are different to those resulting from simply loss of wild-type tumour …
provoke activities that are different to those resulting from simply loss of wild-type tumour …
Gain-of-function mutant p53: all the roads lead to tumorigenesis
Y Stein, V Rotter, R Aloni-Grinstein - International journal of molecular …, 2019 - mdpi.com
The p53 protein is mutated in about 50% of human cancers. Aside from losing the tumor-
suppressive functions of the wild-type form, mutant p53 proteins often acquire inherent …
suppressive functions of the wild-type form, mutant p53 proteins often acquire inherent …
CXCL1: Gene, Promoter, Regulation of Expression, mRNA Stability, Regulation of Activity in the Intercellular Space
J Korbecki, K Barczak, I Gutowska, D Chlubek… - International journal of …, 2022 - mdpi.com
CXCL1 is one of the most important chemokines, part of a group of chemotactic cytokines
involved in the development of many inflammatory diseases. It activates CXCR2 and, at high …
involved in the development of many inflammatory diseases. It activates CXCR2 and, at high …
TP53 mutations in breast and ovarian cancer
L Silwal-Pandit, A Langerød… - Cold Spring …, 2017 - perspectivesinmedicine.cshlp.org
Breast and ovarian cancers are the second and fifth leading causes of cancer deaths among
women. Both breast and ovarian cancers are highly heterogeneous and are presented with …
women. Both breast and ovarian cancers are highly heterogeneous and are presented with …
Gain-of-function mutant p53 promotes cell growth and cancer cell metabolism via inhibition of AMPK activation
G Zhou, J Wang, M Zhao, TX Xie, N Tanaka, D Sano… - Molecular cell, 2014 - cell.com
Many mutant p53 proteins (mutp53s) exert oncogenic gain-of-function (GOF) properties, but
the mechanisms mediating these functions remain poorly defined. We show here that GOF …
the mechanisms mediating these functions remain poorly defined. We show here that GOF …
Transcriptional regulation by wild-type and cancer-related mutant forms of p53
NT Pfister, C Prives - Cold Spring Harbor …, 2017 - perspectivesinmedicine.cshlp.org
TP53 missense mutations produce a mutant p53 protein that cannot activate the p53 tumor
suppressive transcriptional response, which is the primary selective pressure for TP53 …
suppressive transcriptional response, which is the primary selective pressure for TP53 …
Mutant p53 reprograms TNF signaling in cancer cells through interaction with the tumor suppressor DAB2IP
G Di Minin, A Bellazzo, M Dal Ferro, G Chiaruttini… - Molecular cell, 2014 - cell.com
Inflammation is a significant factor in cancer development, and a molecular understanding of
the parameters dictating the impact of inflammation on cancers could significantly improve …
the parameters dictating the impact of inflammation on cancers could significantly improve …